HS Code for Human vaccines

Human vaccines are classified under HS code 3002.41. This classification was refined in the 2022 Harmonized System update to provide better visibility for vaccines used in human medicine. Previously, vaccines were often grouped under broader categories, but the current structure places them within the 3002 heading, which covers blood, antisera, and other immunological products. The classification 3002.41 specifically includes vaccines for human use, whether they are viral, bacterial, or based on newer technologies like mRNA. The logic for this classification is based on the therapeutic and prophylactic nature of the product. By isolating human vaccines into their own subheading, international organizations and customs authorities can more effectively track the global distribution of essential medicines and apply relevant exemptions or expedited clearance procedures.

Products Included

• Viral vaccines for human use (e.g., Influenza, COVID-19)
• Bacterial vaccines (e.g., Tetanus, Cholera)
• mRNA and DNA-based vaccines
• Toxoids and cultures of micro-organisms for human medicine
• Attenuated or inactivated vaccines
• Combined vaccines (e.g., MMR)

Common Misclassification

The most common misclassification occurs with HS code 3002.42, which is reserved for vaccines used in veterinary medicine. While the biological technology may be similar, the intended recipient (human vs. animal) dictates the code. Additionally, some importers mistakenly use 3004, which covers medicaments for therapeutic or prophylactic use that are put up in measured doses. However, vaccines are specifically excluded from 3004 and must be declared under 3002.

FAQ

What is the HS code for human vaccines?

The specific HS code for vaccines used in human medicine is 3002.41.

Does this code include COVID-19 vaccines?

Yes, all COVID-19 vaccines intended for human use are classified under HS code 3002.41.